JKT:CARE

PT Metro Healthcare Indonesia Tbk · JKT · Healthcare · IDR · FY for 2025

Figures on this page computed 2026-11-07 06:53 UTC

Last close

n/aIDR

Market data

We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.

2360.0xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-06
Reported in
IDR
- computed
- Computed from the filing for 2025
1.3%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-06
Reported in
IDR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
1.1%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-06
Reported in
IDR
- Computed from the filing for 2025
- Computed from the filing for 2025
-37.5%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-06
Reported in
IDR
- Computed from the filing for 2025
- Computed from the filing for 2025
0.28Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-06
Reported in
IDR
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-06
Reported in
IDR
- computed

Price is the furthest below its sector's middle: 0.08 against 0.36 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.94x

-0.16x

0.68x

1.64x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales1.94x
Its own average over 9 years, 226.84B.
Profit-0.16x
Its own average over 10 years, -31.22B.
Free cash flow0.68x
Its own average over 10 years, -241.60B.
Debt1.64x
Its own average over 10 years, 508.78B.
Pricen/a
Its own average over 0 years. Market data

Profit is furthest from its own average, at -0.16 times.

The filed years, as a table

Each line is 100 at 2016-12-31, the first year we hold.

Filed year	Sales	Profit	Shares in issue
2016-12-31	n/a	100.0	100.0
2017-12-31	100.0	-110.5	100.0
2018-12-31	279.5	-263.7	100.0
2019-12-31	493.9	-232.2	100.0
2020-12-31	693.3	137.3	100.0
2021-12-31	932.5	58.5	100.0
2022-12-31	834.7	-897.5	100.0
2023-12-31	777.9	-1,064.3	100.0
2024-12-31	1,022.6	-770.6	100.0
2025-12-31	1,409.5	47.5	100.0

How sales was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: IDR

How profit was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: IDR

How shares in issue was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: IDR

Figures behind the shape

Growth

15.3%

faster is higher, placed against 4,950 companies as of 2026-11-06

Five-year revenue growth rate15.3%
Source
computed
Taken on
2026-11-06
Reported in
IDR
- computed
Five-year EPS growth rate-19.0%
Source
computed
Taken on
2026-11-06
Reported in
IDR
- computed
One-year change in net income106.2%
Source
computed
Taken on
2026-11-06
Reported in
IDR
- computed

Returns on capital

1.3%

higher is higher, placed against 5,089 companies as of 2026-11-06

Return on invested capital1.3%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-06
Reported in
IDR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity0.2%
Net Income / Shareholders' Equity x 100
Source
computed
Taken on
2026-11-06
Reported in
IDR
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets0.1%
Net Income / Total Assets x 100
Source
computed
Taken on
2026-11-06
Reported in
IDR
- Computed from the filing for 2025
- Computed from the filing for 2025

Margins

48.9%

wider is higher, placed against 3,412 companies as of 2026-11-06

Gross margin48.9%
Gross Profit / Revenue x 100
Source
computed
Taken on
2026-11-06
Reported in
IDR
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin16.0%
Operating Income / Revenue x 100
Source
computed
Taken on
2026-11-06
Reported in
IDR
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin1.1%
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-06
Reported in
IDR
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin-37.5%
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-06
Reported in
IDR
- Computed from the filing for 2025
- Computed from the filing for 2025

Price

2360.0x

cheaper is higher, placed against 4,362 companies as of 2026-11-06

Price to earnings2360.0x
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-06
Reported in
IDR
- computed
- Computed from the filing for 2025
Price to book3.9x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Taken on
2026-11-06
Reported in
IDR
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA125.8x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Taken on
2026-11-06
Reported in
IDR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio26.8x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Taken on
2026-11-06
Reported in
IDR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025

Safety

0.28

safer is higher, placed against 3,227 companies as of 2026-11-06

Debt to equity0.28
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-06
Reported in
IDR
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio0.84
Current Assets / Current Liabilities
Source
computed
Taken on
2026-11-06
Reported in
IDR
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage0.9x
Operating Income / Interest Expense
Source
computed
Taken on
2026-11-06
Reported in
IDR
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score6.16
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-06
Reported in
IDR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-06
Reported in
IDR
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Taken on
2026-11-06
Reported in
IDR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-06
Reported in
IDR
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.